ArticleCell death & disease2025

GSCs differentiation model-informed nanotherapy: dual-functional brain-targeting liposomes with iRGD modification for co-delivery of osimertinib and bortezomib to combat radioresistant glioblastoma.

Cuiying Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.